Folgen
Lagishetty Chakradhar V
Lagishetty Chakradhar V
Bestätigte E-Mail-Adresse bei its.jnj.com
Titel
Zitiert von
Zitiert von
Jahr
An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract
NPC Fernandes, CV Lagishetty, VS Panda, SR Naik
BMC complementary and alternative medicine 7, 1-8, 2007
3342007
Polyamines: potential anti-inflammatory agents and their possible mechanism of action
CV Lagishetty, SR Naik
Indian journal of pharmacology 40 (3), 121, 2008
702008
A rapid and highly sensitive method for the determination of glimepiride in human plasma by liquid chromatography–electrospray ionization tandem mass spectrometry: application …
L Chakradhar, R Kallem, A Karthik, BT Sundari, S Ramesh, R Mullangi, ...
Biomedical Chromatography 22 (1), 58-63, 2008
382008
Development and validation of a highly sensitive and robust LC-MS/MS with electrospray ionization method for quantification of rosuvastatin in small volume human plasma samples …
RR Kallem, A Karthik, L Chakradhar, R Mullangi, NR Srinivas
Arzneimittelforschung 57 (11), 705-711, 2007
212007
Effects of temsavir, active moiety of antiretroviral agent fostemsavir, on QT interval: results from a phase I study and an exposure–response analysis
C Lagishetty, K Moore, P Ackerman, C Llamoso, M Magee
Clinical and Translational Science 13 (4), 769-776, 2020
182020
Current strategies to streamline pharmacotherapy for older adults
JF Schlender, V Vozmediano, AG Golden, M Rodriguez, TS Samant, ...
European Journal of Pharmaceutical Sciences 111, 432-442, 2018
182018
Simultaneous semimechanistic population analyses of levofloxacin in plasma, lung, and prostate to describe the influence of efflux transporters on drug distribution following …
ES Zimmermann, JV Laureano, CN dos Santos, S Schmidt, CV Lagishetty, ...
Antimicrobial agents and chemotherapy 60 (2), 946-954, 2016
182016
How Informative Are Drug‐Drug Interactions of Gene‐Drug Interactions?
CV Lagishetty, J Deng, LJ Lesko, H Rogers, M Pacanowski, S Schmidt
The Journal of Clinical Pharmacology 56 (10), 1221-1231, 2016
152016
Polyamines in inflammation and their modulation by conventional anti-inflammatory drugs
L Chakradhar V, SR Naik
CSIR, 2007
122007
Evaluation of approaches to deal with low-frequency nuisance covariates in population pharmacokinetic analyses
CV Lagishetty, SB Duffull
The AAPS journal 17, 1388-1394, 2015
92015
A reduction in between subject variability is not mandatory for selecting a new covariate
CV Lagishetty, P Vajjah, SB Duffull
Journal of pharmacokinetics and pharmacodynamics 39 (4), 383-392, 2012
62012
Design of pharmacokinetic studies for latent covariates
CV Lagishetty, CV Coulter, SB Duffull
Journal of pharmacokinetics and pharmacodynamics 39, 87-97, 2012
62012
Population Pharmacokinetic Modeling of Acetaminophen Protein Adducts in Adults and Children
S Jiang, K Madrasi, T Samant, C Lagishetty, V Vozmediano, A Chiew, ...
The Journal of Clinical Pharmacology 60 (5), 595-604, 2020
42020
Probable Mechanism of the Antihyperglycemic Effect of Standardized Extract from Momordica charantia in Streptozotocin Diabetic Rats
SR Naik, SB Bumrela, CV Lagishetty, RV Mandlik
Journal of Complementary and Integrative Medicine 6 (1), 2009
42009
The personalization of drug therapy for elderly patients
JF Schlender, AG Golden, TS Samant, CV Lagishetty, S Schmidt
Developing Drug Products in an Aging Society: From Concept to Prescribing …, 2016
32016
Are We Getting the Best Return on Investment From Clinical Drug‐Drug Interaction Studies?
LJ Lesko, CV Lagishetty
The Journal of Clinical Pharmacology 56 (5), 555-558, 2016
22016
Covariates in pharmacometrics
C Lagishetty
University of Otago, 2013
12013
Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Characterization of Dolutegravir/Rilpivirine Two‐Drug Regimen in the SWORD‐1/‐2 Phase 3 Studies
R Mehta, CV Lagishetty, K Angelis, A Aylott, L Kahl, L Blair, J Mathews, ...
British Journal of Clinical Pharmacology, 2023
2023
Human Systemic Exposure Prediction of GSK2981278 following topical administration using Ex Vivo Human Skin Penetration and Allometric Based Scaling for Dose Determination
CV Lagishetty, LL Santos, J Speitel, C Booth-Genthe, R Singh
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 45, S14-S14, 2018
2018
Pharmacokinetic and pharmacodynamic drug interaction between flibanserin and fluconazole
CV Lagishetty, TS Samant, L Ge, MN Trame, K Natarajan, J Yuan, ...
DRUG METABOLISM REVIEWS 48, 77-77, 2016
2016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20